Antimony Potassium Tartrate is indicated for the treatment of certain conditions, including:

• Schistosomiasis: a parasitic infection caused by schistosomes.
• Leishmaniasis: a parasitic infection caused by Leishmania species.
• Eczema and psoriasis: certain skin conditions where its emetic and diaphoretic properties were historically utilized.

Schistosoma

Leishmaniasis

Psoriasis

Eczema

• The dosage of Antimony Potassium Tartrate should be determined by a qualified healthcare professional based on the specific indication, patient's age, weight, and medical condition.
• The drug is typically administered intravenously (IV) under medical supervision.
• Dosage and treatment duration may vary depending on the severity of the condition being treated.

Adverse reactions to Antimony Potassium Tartrate may include:

• Nausea and vomiting
• Abdominal pain and cramping
• Diarrhea
• Dizziness and lightheadedness
• Sweating and diaphoresis
• Skin rashes or irritation (in the case of topical use)
• Hypersensitivity reactions (rare but possible)

Nausea

Abdominal Cramp

Diarrhea

Dizziness

• Antimony Potassium Tartrate should only be administered by healthcare professionals experienced in handling antimony compounds and under appropriate medical supervision.
• The drug should be used with caution in patients with a history of hypersensitivity reactions to antimony or its derivatives.
• Special caution is required when using Antimony Potassium Tartrate in patients with liver or kidney dysfunction.
• Pregnant women and nursing mothers should avoid using Antimony Potassium Tartrate due to the lack of sufficient safety data.
• Long-term use or high doses of Antimony Potassium Tartrate may lead to toxicity and adverse effects on the cardiovascular system, liver, and kidney function.